{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:39:12Z","timestamp":1791920352207,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["DOH100-99TFDA-P-092"],"award-info":[{"award-number":["DOH100-99TFDA-P-092"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["DOH101-FDA-41103"],"award-info":[{"award-number":["DOH101-FDA-41103"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12072-021-10241-3","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T19:04:46Z","timestamp":1628708686000},"page":"1456-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-2078","authenticated-orcid":false,"given":"Yi-Shin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Tsung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin-Ho","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Tan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"10241_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","volume":"15","author":"H Devarbhavi","year":"2021","unstructured":"Devarbhavi H, Aithal G, Treeprasertsuk S, et al. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258\u2013282","journal-title":"Hepatol Int"},{"key":"10241_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.14309\/ajg.0000000000000201","volume":"114","author":"H Devarbhavi","year":"2019","unstructured":"Devarbhavi H, Choudhury AK, Sharma MK, APASL ACLF working party, et al. Drug-induced acute-on-chronic liver failure in Asian patients. Am J Gastroenterol 2019;114:929\u2013937","journal-title":"Am J Gastroenterol"},{"key":"10241_CR3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/liv.13662","volume":"38","author":"H Devarbhavi","year":"2018","unstructured":"Devarbhavi H, Patil M, Reddy VV, et al. Drug-induced acute liver failure in children and adults: results of a single-centre study of 128 patients. Liver Int 2018;38:1322\u20131329","journal-title":"Liver Int"},{"key":"10241_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1055\/s-0034-1375958","volume":"34","author":"VJ Navarro","year":"2014","unstructured":"Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis 2014;34:172\u2013193","journal-title":"Semin Liver Dis"},{"key":"10241_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/hep.27317","volume":"60","author":"VJ Navarro","year":"2014","unstructured":"Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the US drug-induced liver injury network. Hepatology 2014;60:1399\u20131408","journal-title":"Hepatology"},{"key":"10241_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1053\/j.gastro.2014.12.004","volume":"148","author":"LB Seeff","year":"2015","unstructured":"Seeff LB, Bonkovsky HL, Navarro VJ, et al. Herbal products and the liver: a review of adverse effects and mechanisms. Gastroenterology 2015;148:517\u2013532","journal-title":"Gastroenterology"},{"issue":"9","key":"10241_CR7","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/ijms17091488","volume":"17","author":"R Teschke","year":"2016","unstructured":"Teschke R, Andrade RJ. Drug, herb, and dietary supplement hepatotoxicity. Int J Mol Sci 2016;17(9):1488","journal-title":"Int J Mol Sci"},{"key":"10241_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology 2017;65:363\u2013373","journal-title":"Hepatology"},{"issue":"10","key":"10241_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/medicines7100062","volume":"79","author":"R Teschke","year":"2020","unstructured":"Teschke R, Danan G. Worldwide use of RUCAM for causality assessment in 81,856 idiosyncratic DILI and 14,029 HILI cases published 1993-Mid 2020: a comprehensive analysis. Medicines (Basel) 2020;79(10):62","journal-title":"Medicines (Basel)"},{"key":"10241_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14218\/JCTH.2017.00033","volume":"6","author":"J Jing","year":"2018","unstructured":"Jing J, Teschke R. Traditional Chinese medicine and herb-induced liver injury: comparison with drug-induced liver injury. J Clin Transl Hepatol 2018;6:57\u201368","journal-title":"J Clin Transl Hepatol"},{"key":"10241_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14218\/JCTH.2020.00009","volume":"8","author":"R Teschke","year":"2020","unstructured":"Teschke R, Zhu Y, Jing J. Herb-induced liver injury in Asia and current role of RUCAM for causality assessment in 11,160 published cases. J Clin Transl Hepatol 2020;8:200\u2013214","journal-title":"J Clin Transl Hepatol"},{"key":"10241_CR12","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 2015;148:1340\u20131352","journal-title":"Gastroenterology"},{"key":"10241_CR13","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology 2019;156:2230\u20132241","journal-title":"Gastroenterology"},{"key":"10241_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jfda.2013.10.001","volume":"22","author":"LH Chih","year":"2014","unstructured":"Chih LH, On AWF, Huang YS. Correlation of anti-tuberculosis drug-related liver injury and liver function monitoring: a 12 years\u2019 experience in Taiwan Drug Relieve Foundation. J Food Drug Anal 2014;22:356\u2013362","journal-title":"J Food Drug Anal"},{"key":"10241_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","volume":"32","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, DILIN Study Group. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009;32:55\u201368","journal-title":"Drug Saf"},{"key":"10241_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meeting: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323\u20131330","journal-title":"J Clin Epidemiol"},{"key":"10241_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328\u2013357","journal-title":"Hepatology"},{"key":"10241_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 2006;43:1317\u20131325","journal-title":"Hepatology"},{"key":"10241_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"J Wendon","year":"2017","unstructured":"Wendon J, Cordoba J, Dhawan A, et al. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66:1047\u20131081","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"10241_CR20","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","volume":"62","author":"V Arroyo","year":"2015","unstructured":"Arroyo V, Moreau R, Jalan R, EASL-CLIF Consortium CANONIC Study, et al. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol 2015;62(1 Suppl):S131\u2212S143","journal-title":"J Hepatol"},{"key":"10241_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cgh.2017.12.051","volume":"16","author":"I Medina-Caliz","year":"2018","unstructured":"Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A, et al. Herbal and dietary supplement-induced liver injuries in the Spanish DILI Registry. Clin Gastroenterol Hepatol 2018;16:1495\u20131502","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10241_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","volume":"75","author":"C Stephens","year":"2021","unstructured":"Stephens C, Robles-Diaz M, Medina-Caliz I, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol 2021;75:86\u201397","journal-title":"J Hepatol"},{"key":"10241_CR23","doi-asserted-by":"crossref","unstructured":"Bessone F, Garc\u00eda-Cort\u00e9s M, Medina-Caliz I, et al. Herbal and dietary supplements-induced liver injury in Latin America: Experience from the Latindili Network. Clin Gastroenterol Hepatol 2021. (Epub ahead of print)","DOI":"10.1016\/j.cgh.2021.01.011"},{"key":"10241_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jceh.2020.11.002","volume":"11","author":"H Devarbhavi","year":"2021","unstructured":"Devarbhavi H, Joseph T, Sunil Kumar N, The Indian Network of Drug-Induced Liver Injury, et al. Etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol 2021;11:288\u2013298","journal-title":"J Clin Exp Hepatol"},{"key":"10241_CR25","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ajg.2012.138","volume":"107","author":"KT Suk","year":"2012","unstructured":"Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012;107:1380\u20131387","journal-title":"Am J Gastroenterol"},{"key":"10241_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/aje\/kwh207","volume":"160","author":"K Radimer","year":"2004","unstructured":"Radimer K, Bindewald B, Hughes J, et al. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999\u20132000. Am J Epidemiol 2004;160:339\u2013349","journal-title":"Am J Epidemiol"},{"key":"10241_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hep.510310129","volume":"31","author":"WM Wong","year":"2000","unstructured":"Wong WM, Wu PC, Yuen MF, et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology 2000;31:201\u2013206","journal-title":"Hepatology"},{"key":"10241_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jcma.2015.12.006","volume":"79","author":"NT Wang","year":"2016","unstructured":"Wang NT, Huang YS, Lin MH, et al. Chronic hepatitis B infection and risk of anti-tuberculosis drug-induced liver injury: systematic review and meta-analysis. J Chin Med Assoc 2016;79:368\u2013374","journal-title":"J Chin Med Assoc"},{"key":"10241_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12664-017-0815-8","volume":"37","author":"CA Philips","year":"2018","unstructured":"Philips CA, Paramaguru R, Joy AK, et al. Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury\u2014a single-center experience from southern India. Indian J Gastroenterol 2018;37:9\u201317","journal-title":"Indian J Gastroenterol"},{"key":"10241_CR30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep4.1355","volume":"3","author":"CA Philips","year":"2019","unstructured":"Philips CA, Paramaguru R, Augustine P, et al. A single-center experience on outcomes of complementary and alternative medicine use among patients with cirrhosis. Hepatol Commun 2019;3:1001\u20131012","journal-title":"Hepatol Commun"},{"key":"10241_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, APASL ACLF Research Consortium (AARC) for APASL ACLF working Party, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int 2019;13:353\u2013390","journal-title":"Hepatol Int"},{"key":"10241_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","volume":"141","author":"TJ Davern","year":"2011","unstructured":"Davern TJ, Chalasani N, Fontana RJ, Drug-Induced Liver Injury Network (DILIN), et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;141:1665\u20131672","journal-title":"Gastroenterology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10241-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T07:18:29Z","timestamp":1699341509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10241"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10241-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yi-Shin Huang, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, and Yi-Hsiang Huang declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study is not an animal research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research (ethics)"}},{"value":"Our research complies with the guidelines for human studies and has been conducted ethically in accordance with the World Medical Association Declaration of Helsinki. This study was approved by the Institutional Review Board of each participating hospital for all the data collection and analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (ethics)"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish (ethics)"}},{"value":"None.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Plant reproducibility"}}]}}